Nussbaum Rodney L 4
4 · GYRE THERAPEUTICS, INC. · Filed Mar 21, 2024
Insider Transaction Report
Form 4
Nussbaum Rodney L
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-03-20+1,866→ 1,866 totalExercise: $17.86Exp: 2034-03-20→ Common Stock (1,866 underlying)
Footnotes (1)
- [F1]These options vest as to one-third on each of the first, second and third anniversaries of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date.